Editorial: CRISPR advancement in cancer research and future perspectives.
作者信息
Biagioni Alessio, Mohammadinejad Reza
机构信息
Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Firenze, Italy.
Research Center of Tropical and Infectious Diseases, Kerman University of Medical Sciences, Kerman, Iran.
出版信息
Front Oncol. 2023 Mar 9;13:1173527. doi: 10.3389/fonc.2023.1173527. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: CRISPR advancement in cancer research and future perspectives.社论：CRISPR在癌症研究中的进展及未来展望
Front Oncol. 2023 Mar 9;13:1173527. doi: 10.3389/fonc.2023.1173527. eCollection 2023.
2
CRISPR/Cas9: Transcending the Reality of Genome Editing.CRISPR/Cas9：超越基因组编辑的现实
Mol Ther Nucleic Acids. 2017 Jun 16;7:211-222. doi: 10.1016/j.omtn.2017.04.001. Epub 2017 Apr 8.
3
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.组织特异性递送 CRISPR 治疗药物：非病毒载体的策略和机制。
Int J Mol Sci. 2020 Oct 5;21(19):7353. doi: 10.3390/ijms21197353.
4
CRISPR-Cas systems: Challenges and future prospects.CRISPR-Cas 系统：挑战与未来前景。
Prog Mol Biol Transl Sci. 2021;180:141-151. doi: 10.1016/bs.pmbts.2021.01.008. Epub 2021 Feb 15.
5
CRISPR in personalized medicine: Industry perspectives in gene editing.CRISPR 在个性化医疗中的应用：基因编辑的行业视角。
Semin Perinatol. 2018 Dec;42(8):501-507. doi: 10.1053/j.semperi.2018.09.008. Epub 2018 Oct 2.
6
CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.CRISPR-cas9 基因组编辑递送系统用于靶向癌症治疗。
Life Sci. 2021 Feb 15;267:118969. doi: 10.1016/j.lfs.2020.118969. Epub 2020 Dec 29.
7
Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics.CRISPR/Cas9 与人工智能的融合用于改善癌症治疗。
J Transl Med. 2022 Nov 18;20(1):534. doi: 10.1186/s12967-022-03765-1.
8
Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.CRISPR/Cas9 基因编辑在癌症中的当前应用和未来展望。
Mol Cancer. 2022 Feb 21;21(1):57. doi: 10.1186/s12943-022-01518-8.
9
Advances in CRISPR Delivery Methods: Perspectives and Challenges.CRISPR 递送方法的进展：观点和挑战。
CRISPR J. 2022 Oct;5(5):660-676. doi: 10.1089/crispr.2022.0051.
10
Advancements in CRISPR/Cas9 technology-Focusing on cancer therapeutics and beyond.CRISPR/Cas9 技术的进展——聚焦癌症治疗及其他领域。
Semin Cell Dev Biol. 2019 Dec;96:13-21. doi: 10.1016/j.semcdb.2019.05.026. Epub 2019 May 31.
引用本文的文献
1
Bridging the gap between omics research and dental practice.弥合组学研究与牙科实践之间的差距。
BDJ Open. 2024 Mar 4;10(1):16. doi: 10.1038/s41405-024-00199-3.
本文引用的文献
1
CRISPR technology: A decade of genome editing is only the beginning.CRISPR技术：基因组编辑的十年仅仅是个开始。
Science. 2023 Jan 20;379(6629):eadd8643. doi: 10.1126/science.add8643.
2
CRISPR in cancer biology and therapy.CRISPR在癌症生物学与治疗中的应用
Nat Rev Cancer. 2022 May;22(5):259-279. doi: 10.1038/s41568-022-00441-w. Epub 2022 Feb 22.
3
Editing Genes by CRISPR-Cas: Current Insights and Future Perspectives.CRISPR-Cas 基因编辑：当前的见解和未来的展望。
Int J Mol Sci. 2021 Oct 20;22(21):11321. doi: 10.3390/ijms222111321.
4
CAR T-Cell Therapy in Hematological Malignancies.血液系统恶性肿瘤中的嵌合抗原受体T细胞疗法
Int J Mol Sci. 2021 Aug 20;22(16):8996. doi: 10.3390/ijms22168996.
5
uPAR Knockout Results in a Deep Glycolytic and OXPHOS Reprogramming in Melanoma and Colon Carcinoma Cell Lines.uPAR 敲除导致黑色素瘤和结肠癌细胞系的深度糖酵解和 OXPHOS 重编程。
Cells. 2020 Jan 28;9(2):308. doi: 10.3390/cells9020308.
6
EMT signaling: potential contribution of CRISPR/Cas gene editing.EMT 信号转导：CRISPR/Cas 基因编辑的潜在贡献。
Cell Mol Life Sci. 2020 Jul;77(14):2701-2722. doi: 10.1007/s00018-020-03449-3. Epub 2020 Feb 1.
7
Type II CRISPR/Cas9 approach in the oncological therapy.II型CRISPR/Cas9方法在肿瘤治疗中的应用。
J Exp Clin Cancer Res. 2017 Jun 15;36(1):80. doi: 10.1186/s13046-017-0550-0.
8
CRISPR gene-editing tested in a person for the first time.CRISPR基因编辑首次在人体中进行测试。
Nature. 2016 Nov 24;539(7630):479. doi: 10.1038/nature.2016.20988.
9
Genome editing. The new frontier of genome engineering with CRISPR-Cas9.基因组编辑。CRISPR-Cas9 技术引领的基因组工程新前沿。
Science. 2014 Nov 28;346(6213):1258096. doi: 10.1126/science.1258096.
Zotero 插件